patent for ICT-121, a cancer stem cell-targeted immunotherapy

8,367,405, related to its Mesenchymal Precursor Cell adult stem cell technology platform

10/969,011 for its lead product ATIR, a cell-based product that aids stem cell transplants from mismatched donors...8,343,485, "Compositions and Methods of Vascular Injury Repair," for AMR-001, its stem cell therapy product

7,927,587, related to using non-embryonic, multipotent stem cells in lysosomal storage diseases, such as Hurler's syndrome and Fabry's disease, as well as other disorders

8,147,824, which covers the use of nonembryonic, multipotent stem cells for the reduction in severity or prevention of graft-vs.-host disease

ImmunoCellular Therapeutics Ltd., of Los Angeles, received a notice of allowance for a patent, titled "Cancer Stem Cell Antigen Vaccines and Methods," which covers various methods of using dendritic cells combined with antigens derived from glioblastoma cancer stem cells for treating glioblastoma multiforme

8,044,201, titled "Stem Cell Cultures," which claims Thiazovivin, a small-molecule Rho-associated kinase inhibitor, as well as compositions and cell culture media comprising Thiazovivin

Stem Cell Therapeutics Corp., of Calgary, Alberta, said it received U.S. Patent No...7,994,131, titled "Stimulation of Proliferation of Pluripotent Stem Cells through Administration of Pregnancy Associated Compounds

8,017,393, which covers the firm's method for generating and expanding hemangioblast cells from human embryonic stem cells

Stem Cell Therapeutics Corp., of Calgary, Alberta, received U.S. Patent No

7,935,528 relating to the isolation and use of human liver stem cells to treat liver disease

Stem Cell Therapeutics Corp., of Calgary, Alberta, received U.S. Patent No...7,884,072 titled, "Prolactin induced increase in neural stem cell number

7,659,118, covering non-embryonic multipotent stem cells, their isolation and expansion and related pharmaceutical compositions...Fate Therapeutics Inc., of San Diego, was issued a patent titled "Methods for Reprogramming Somatic Cells," which covers foundational induced pluripotent stem cell technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency genes, small molecules and biologics

Stem Cell Therapeutics Corp., of Calgary, Alberta, was granted U.S. Patent No

Stem Cell Therapy International Inc., of Tampa, Fla., said subsidiary Histostem Ltd., of South Korea, was granted U.S. Patent No...7,582,477 B2, titled "Method of Isolating and Culturing Mesenchymal Stem Cell Derived from Cryopreserved Umbilical Cord Blood

7,527,971 titled, "Generation and Differentiation of Adult Stem Cells

Stem Cell Therapeutics Corp., of Calgary, Alberta, was issued U.S. Patent No

Neuralstem Inc., of Rockville, Md., received a notice of allowance for a patent regarding stable neural stem cell lines...It covers the technology to immortalize any human neural stem cell

The company also received a notice of allowance for a patent relating to the production of neural stem cells...That covers methods of selectively removing cancer cells ex vivo from blood stem cells and other organs using reovirus